After a blustery few years, the winds are shifting for biotech stocks. A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting …
Investing Over the Long-Term with No Debt
Biotech stocks set for a rebound in 2024, analysts say
After a blustery few years, the winds are shifting for biotech stocks. A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting …
0 Comments